Showing results (2461-2470 of 2,709) with videos related to

Sort By:
Pageof 271
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2018
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapyY-P Chen, Y-Q Wang, J-W Lv, et al.
Journal of the American College of Radiology : JACR|November 6, 2018
ACR Appropriateness Criteria® Evaluation of the Symptomatic Male Breast, Bethany L Niell, Ana P Lourenco, et al.
Brain, Behavior, and Immunity|April 27, 2020
Baseline immunoreactivity before pregnancy and poly(I:C) dose combine to dictate susceptibility and resilience of offspring to maternal immune activationMyka L Estes, Kathryn Prendergast, Jeremy A MacMahon, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|September 15, 2022
Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammationSi-Nan Lin, Alessandro Musso, Jie Wang, et al.
Vaccines|May 9, 2020
Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse ModelsWilson Nguyen, Eri Nakayama, Kexin Yan, et al.
JCI Insight|February 24, 2025
SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosisStephanie T Le, Alina I Marusina, Alexander A Merleev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2019
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)Dung T Le, Vincent J Picozzi, Andrew H Ko, et al.
Nature Medicine|April 25, 2018
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2013
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancerJoseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Oncotarget|August 24, 2014
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinomaOihana Murillo-Sauca, Man Ki Chung, June Ho Shin, et al.
Pageof 271